Given the patient's BMI of 27.3 kg/m2 and their current contraceptive medications, which clinical interpretation is most appropriate regarding their risk for venous thromboembolism (VTE)?
The patient's BMI categorizes them as obese, significantly increasing their VTE risk with hormonal contraceptives. The patient's BMI does not significantly increase their risk of VTE when using hormonal contraceptives. Higher education and unemployment are significant risk factors for VTE in this context. The combination of multiple hormonal contraceptive methods significantly increases VTE risk regardless of BMI.